May 2022 Br J Cardiol 2022;29:64–6 doi:10.5837/bjc.2022.018
Mateusz Wawrzeńczyk, Marcin D Grabowski
Introduction The COVID-19 pandemic has posed a serious threat to global health worldwide. In an acute disease process, which is the case in COVID-19, electrocardiography (ECG) abnormalities are common, present in up to 93% of hospitalised critically ill patients.1 Any specific ECG alteration criteria could help emergency clinicians establish the prognosis and assess the risk of adverse events resulting from coronavirus infection. The purpose of this meta-analysis was to assess the prognostic value of the admission ECG (specifically: the duration of the PR interval, the QTc interval and the QRS complex and the heart rate [HR]) in COVID-19 pati
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits